Kian Hoe graduated from the Imperial College London with First Class Honours in Biochemistry. He pursued his postgraduate studies at the University of Cambridge, where he was awarded his PhD in Protein Engineering for the biophysical studies on the p53 tumour suppressor protein. He was funded by an A*STAR National Science Scholarship (BS-PhD) for both his undergraduate and postgraduate studies.
Kian Hoe returned to Singapore where he worked as a Research Fellow at the p53lab, A*STAR, where his research involved understanding the molecular basis of resistance towards drug-induced apoptosis in acute myeloid leukemia, in a collaboration with Roche Pharmaceuticals. He was also involved in a number of antibody development projects, including the development of highly sensitive diagnostics against prostate specific antigen for the early detection of prostate cancer in collaboration with the Data Storage Institute, A*STAR, as well as an antibody diagnostic validation project with the Singapore Bioimaging Consortium and ImaginAb as an imaging tool. He had co-authored a number of research articles in peer-reviewed international journals. He is also currently an adjunct lecturer at the Lee Kong Chian School of Medicine.
Kian Hoe has experience in the drafting and prosecution of patents in Southeast Asia, particularly in the areas of life science, biotechnology and molecular biology. He is a registered Singapore Patent Attorney and is a member of the Association of Singapore Patent Attorneys (ASPA).